INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 27
RESEARCH DOSSIER / NOT AN ENDORSEMENT

AlyveRx (Alyve)

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Weight loss built for your health'; PermeAct sublingual delivery tech; 10,000+ patients, Trustpilot 4.7 claim; injectable and injection-free options; also NAD+, glutathione, sermorelin.

Audienceread

READ: needle-averse and biohacker/longevity-leaning adults, self-pay (no insurance), accepts both budget compounded and premium brand pricing.

Pricing & termsverified

Compounded semaglutide from $183/mo; compounded tirzepatide $283/mo; sema drops $203; tirz drops $249; Mounjaro $1,395, Wegovy $1,695, Ozempic $1,395 per month listed.

Clinical relationshipspartial

Alyve, Inc. is an MSO; care by 'independent licensed healthcare providers operating through affiliated professional entities'; entities not named.

Pharmacy & fulfillmentpartial

Unnamed 'licensed pharmacies and compounding facilities'.

Advertising snapshotsnapshot

Meta US active advertiser page: 0 results. Google US last-30-days domain search: 0 ads.

Founding yearnot_found

Not found.

    Founderspartial

    Homepage names Steve Kushner as Founder, Chief Scientist and Formulator. No verified connection to similarly named businesses; other founders not established.

    Location & entity contextpartial

    Third-party review says Alyve, Inc. Mount Dora FL; not confirmed first-party.

    Search visibility samplesnapshot

    Free domain-restricted search returned 1 result(s) in a bounded sample, not an indexed-page count; top pages listed in sources. No rank/traffic data (paid analytics excluded).

    THE MODERN DOSING WEEKLY

    The peptide news
    that changes your week.

    Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.